Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo
- PMID: 19270722
- PMCID: PMC4002272
- DOI: VSports在线直播 - 10.1038/aps.2009.19
"VSports app下载" Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo
Abstract
Aim: The aim of this study was to explore the effects and mechanism of berbamine on imatinib-resistant BCR-ABL-positive human leukemia K562 (K562-r) cells in vitro and in vivo VSports手机版. .
Methods: Cell viability was measured by MTT assay, and apoptotic morphology changes were detected by fluorescence microscopy. The apoptosis rate was measured by flow cytometric assay. mdr-1 mRNA levels were determined by RT-PCR. Bcl-2 family proteins, cytochrome c(cyt C), poly (ADP-ribose) polymerase (PARP), and P-glycoprotein were detected by Western blot. BALB/c nu/nu mice were injected with K562-r cells subcutaneously. Tumor-bearing mice were treated intravenously with berbamine V体育安卓版. .
Results: MTT tests revealed that berbamine significantly inhibited K562-r cell proliferation and increased the chemo-sensitivity of K562-r cells to imatinib. The apoptosis rate was significantly increased following treatment with 21. 2 micromol/L berbamine; formation of typical apoptotic blebs was apparent, as observed by fluorescence microscopy. Expression levels of mdr-1 mRNA and P-gp protein were high in untreated K562-r cells and significantly down-regulated by berbamine treatment. Berbamine-treated K562-r cells also exhibited down-regulated expression of the anti-apoptotic proteins Bcl-2 and Bcl-x(L), up-regulated expression of the apoptotic proteins Bax and cytoplasmic cyt C, and stimulated proteolytic cleavage of PARP. In addition, berbamine also suppressed the growth of K562-r xenotransplanted tumors in vivo V体育ios版. .
Conclusion: Berbamine inhibited proliferation of K562-r cells both in vitro and in vivo. Berbamine-induced apoptosis in K562-r cells appeared to occur through a mechanism involving Bcl-2 family proteins, as well as mdr-1 mRNA and P-gp protein. Berbamine in combination with imatinib restored the chemo-sensitivity of K562-r cells to imatinib. Our findings suggest that berbamine may be useful in treating imatinib-resistant CML patients. VSports最新版本.
Figures (V体育ios版)



"VSports注册入口" References
-
- Nowell P, Hungerford D. A minute chromosome in human chronic granulocytic leukemia. Science. 1960;132:1497. - "V体育平台登录" PubMed
-
- Konopka JB, Watanabe SM, Witte ON. An alteration of the human c-ABL protein in K562 leukemia-cells unmasks associated tyrosine kinase-activity. Cell. 1984;37:1035–42. - PubMed
-
- Kirchner D, Duyster J, Ottmann O, Schmid RM, Bergmann L, Munzert G. Mechanisms of bcr-Abl-mediated NF-kappa B/Re1 activation. Exp Hematol. 2003;31:504–11. - PubMed
-
- Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia. 2004;18:189–218. - PubMed
-
- Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. New Engl J Med. 2006;355:2408–17. - PubMed (V体育安卓版)
Publication types
MeSH terms (VSports手机版)
- "V体育官网" Actions
- "V体育安卓版" Actions
- Actions (VSports app下载)
- V体育ios版 - Actions
- "V体育官网" Actions
Substances
- "V体育ios版" Actions
- VSports最新版本 - Actions
- Actions (V体育平台登录)
- V体育官网入口 - Actions
- V体育2025版 - Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources (VSports)
Medical
Research Materials
Miscellaneous